
33rd ECFS, VALENCIA, SPAIN, 16-19 June 2010
Mon, 04/19/2010
‘The European Cystic Fibrosis Society (ECFS) aims to achieve the best possible treatment and the highest quality of life for the patient with cystic fibrosis by the development and distribution of knowledge in the field of cystic fibrosis... The objective of this conference is to provide a forum for the discussion of the best basic and applied science, and facilitate translation of the latest knowledge into daily clinical practice. ‘ www.ecfs.eu
![]() |
| Philippe BORDEAU CEO |
We would be glad to meet you there
to exchange on the development of Meveol (OSCN/Lactoferrin)
and the progress expected for CF patients.
to exchange on the development of Meveol (OSCN/Lactoferrin)
and the progress expected for CF patients.
Come to see us on our booth 13b
![]() |
![]() |
|
![]() |
| Philippe NUSSBAUMER Patient Organization & NPO Relationship |
Monique LANDY International Relationship |
Emmanuelle GEORGI, PharmD Research & Development |

Development of a treatment to fight against Cystic Fibrosis
The regulatory preclinical study was co-financed by E.U. Europe is moving in Rhone Alpes with the European Regional Development Fund.




